196 related articles for article (PubMed ID: 30483480)
1. Cellular Markers of Active Disease and Cure in Different Forms of
Botana L; Matía B; San Martin JV; Romero-Maté A; Castro A; Molina L; Fernandez L; Ibarra-Meneses A; Aguado M; Sánchez C; Horrillo L; Chicharro C; Nieto J; Ortega S; Ruiz-Giardin JM; Carrillo E; Moreno J
Front Cell Infect Microbiol; 2018; 8():381. PubMed ID: 30483480
[TBL] [Abstract][Full Text] [Related]
2. Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant Recipients.
Carrillo E; Carrasco-Antón N; López-Medrano F; Salto E; Fernández L; San Martín JV; Alvar J; Aguado JM; Moreno J
PLoS Negl Trop Dis; 2015; 9(10):e0004179. PubMed ID: 26496365
[TBL] [Abstract][Full Text] [Related]
3. Antigenicity of
Fernández L; Carrillo E; Sánchez-Sampedro L; Sánchez C; Ibarra-Meneses AV; Jimenez MA; Almeida VDA; Esteban M; Moreno J
Front Immunol; 2018; 9():843. PubMed ID: 29740446
[No Abstract] [Full Text] [Related]
4. IFN-γ, IL-2, IP-10, and MIG as Biomarkers of Exposure to
Ibarra-Meneses AV; Ghosh P; Hossain F; Chowdhury R; Mondal D; Alvar J; Moreno J; Carrillo E
Front Cell Infect Microbiol; 2017; 7():200. PubMed ID: 28620584
[TBL] [Abstract][Full Text] [Related]
5. Asymptomatic immune responders to Leishmania among HIV positive patients.
Botana L; Ibarra-Meneses AV; Sánchez C; Castro A; San Martin JV; Molina L; Ruiz-Giardin JM; Carrillo E; Moreno J
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007461. PubMed ID: 31158223
[TBL] [Abstract][Full Text] [Related]
6. F1 Domain of the
Carrillo E; Fernandez L; Ibarra-Meneses AV; Santos MLB; Nico D; de Luca PM; Correa CB; de Almeida RP; Moreno J; Palatnik-de-Sousa CB
Front Immunol; 2017; 8():750. PubMed ID: 28747911
[TBL] [Abstract][Full Text] [Related]
7. Leishmania infantum-specific IFN-γ production in stimulated blood from cats living in areas where canine leishmaniosis is endemic.
Priolo V; Martínez-Orellana P; Pennisi MG; Masucci M; Prandi D; Ippolito D; Bruno F; Castelli G; Solano-Gallego L
Parasit Vectors; 2019 Mar; 12(1):133. PubMed ID: 30909952
[TBL] [Abstract][Full Text] [Related]
8. Atypical presentation in adults in the largest community outbreak of leishmaniasis in Europe (Fuenlabrada, Spain).
Horrillo L; San Martín JV; Molina L; Madroñal E; Matía B; Castro A; García-Martínez J; Barrios A; Cabello N; Arata IG; Casas JM; Ruiz Giardin JM
Clin Microbiol Infect; 2015 Mar; 21(3):269-73. PubMed ID: 25658537
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?
Horrillo L; Castro A; Matía B; Molina L; García-Martínez J; Jaqueti J; García-Arata I; Carrillo E; Moreno J; Ruiz-Giardin JM; San Martín J
Parasit Vectors; 2019 Jul; 12(1):359. PubMed ID: 31340851
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and Functional Profiles of Antigen-Specific CD4
Egui A; Ledesma D; Pérez-Antón E; Montoya A; Gómez I; Robledo SM; Infante JJ; Vélez ID; López MC; Thomas MC
Front Cell Infect Microbiol; 2018; 8():393. PubMed ID: 30510917
[TBL] [Abstract][Full Text] [Related]
11. Pediatric visceral leishmaniasis: a retrospective study to propose the diagnostic tests algorithm in southern Iran.
Rezaei Z; Pourabbas B; Asaei S; Kühne V; Sepehrpour S; Pouladfar G; Keihani N; Büscher P
Parasitol Res; 2021 Apr; 120(4):1447-1453. PubMed ID: 33576903
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of methods for detection of asymptomatic individuals infected with Leishmania infantum in the state of Piauí, Brazil.
Porcino GN; Carvalho KSS; Braz DC; Costa Silva V; Costa CHN; de Miranda Santos IKF
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007493. PubMed ID: 31260440
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of immunochromatographic dipstick test (ICT) rk39, soluble antigen ELISA and IFAT for the sero-diagnosis of visceral leishmaniasis in Morocco.
Mniouil M; Fellah H; Amarir F; Sadak A; Et-Touys A; Bakri Y; Moustachi A; Tassou FZ; Hida M; Lyagoubi M; Adlaoui EB; Rhajaoui M; Sebti F
Acta Trop; 2018 Jun; 182():185-189. PubMed ID: 29545149
[TBL] [Abstract][Full Text] [Related]
14. IL-15 in human visceral leishmaniasis caused by Leishmania infantum.
Milano S; Di Bella G; D'Agostino P; Barbera C; Caruso R; La Rosa M; Ferlazzo V; Vitale G; La Russa C; Gambino G; Chifari N; Mansueto S; Cillari E
Clin Exp Immunol; 2002 Feb; 127(2):360-5. PubMed ID: 11876762
[TBL] [Abstract][Full Text] [Related]
15. Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis.
Portela ÁSB; Costa LE; Salles BCS; Lima MP; Santos TTO; Ramos FF; Lage DP; Martins VT; Caligiorne RB; Lessa DR; Silva FR; Machado AS; Nascimento GF; Gama IS; Chávez-Fumagalli MA; Teixeira AL; Rocha MOC; Rocha RL; Coelho EAF
Immunobiology; 2018 Mar; 223(3):303-309. PubMed ID: 29074301
[TBL] [Abstract][Full Text] [Related]
16. Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis.
Carvalho AM; Magalhães A; Carvalho LP; Bacellar O; Scott P; Carvalho EM
BMC Infect Dis; 2013 Nov; 13():529. PubMed ID: 24206576
[TBL] [Abstract][Full Text] [Related]
17. Use of an Interferon Gamma Release Assay (IGRA) to test T-cell responsiveness to soluble Leishmania infantum antigen in whole blood of dogs from endemic areas.
Zribi L; El-Goulli AF; Ben-Abid M; Gharbi M; Ben-Sghaier I; Boufaden I; Aoun K; Bouratbine A
Vet Parasitol; 2017 Nov; 246():88-92. PubMed ID: 28969786
[TBL] [Abstract][Full Text] [Related]
18. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.
Singh OP; Gidwani K; Kumar R; Nylén S; Jones SL; Boelaert M; Sacks D; Sundar S
Clin Vaccine Immunol; 2012 Jun; 19(6):961-6. PubMed ID: 22539471
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
20. Induction and abrogation of LACK reactive cells in the evolution of human leishmaniasis.
Maasho K; Wolday D; Edjigu M; Söderström K; Britton S; Akuffo H
Clin Exp Immunol; 2001 May; 124(2):255-61. PubMed ID: 11422202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
